Landmark Bio


Landmark Bio translates groundbreaking research into life-changing medicines. We provide development, manufacturing, and regulatory capabilities to help life science innovators rapidly progress advanced therapies from bench to clinic with a line of sight to commercialization.

Based in Watertown, MA, Landmark Bio brings together the best of industry, academia and research hospitals to accelerate life sciences innovation. Our founders include Harvard University, Massachusetts Institute of Technology, Cytiva, FUJIFILM Diosynth Biotechnologies, and Alexandria Real Estate Equities, Inc. Collaborating partners include Massachusetts General Brigham, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and Boston Children’s Hospital.